PUX-31629-31840 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-18
Dose 1 — Janssen/Johnson & Johnson
2021-10-08
Registered in v-safe
2021-11-17
Health check-in — 3 months, dose 1
Feeling: Fair

Adult check-in
2022-02-16
Survey response — 6 months, dose 1
MedDRA: Abortion spontaneous, Diabetes mellitus, Hypertension — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: High Blood Pressure, Diabetes and a Miscarriage

MedDRA releases: 2024-11 · check-in free text available
2022-02-16
Report sent to call center — 6 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2022-02-17
Call 1 — Left Voicemail
2022-08-18
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-18	Janssen/Johnson & Johnson	No

Call center

Reported	Outcome	VAERS-related outcome
2022-02-16	Unsuccessful

Free text

Release 11 — 6 months, dose 1

2022-02-16

Symptoms: High Blood Pressure, Diabetes and a Miscarriage

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	·	·	✓
SD	Diabetes mellitus	·	·	✓
SD	Hypertension	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release